Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Tarsus Pharmaceuticals, Inc.(TARS) | 607,689 | 485,021 | -122,668 | $33.65M | $24.92M | 8.12% | -$8.73M |
| Crinetics Pharmaceuticals In | 516,431 | 523,431 | +7,000 | $26.41M | $17.56M | 5.72% | -$8.85M |
| State Street SPDR S&P 500 ETF TrustTR UNIT(SPY) | 0 | 25,000 | +25,000 | $0 | $13.98M | 4.56% | +$13.98M |
| Sarepta Therapeutics, Inc.(SRPT) | 34,087 | 169,087 | +135,000 | $4.14M | $10.79M | 3.52% | +$6.65M |
| Blueprint Medicines Corp | 169,374 | 113,904 | -55,470 | $14.77M | $10.08M | 3.28% | -$4.69M |
| Akero Therapeutics Inc | 0 | 245,000 | +245,000 | $0 | $9.92M | 3.23% | +$9.92M |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 0 | 31,594 | +31,594 | $0 | $8.53M | 2.78% | +$8.53M |
| TG Therapeutics, Inc.(TGTX) | 291,240 | 210,065 | -81,175 | $8.77M | $8.28M | 2.70% | -$483.5K |
| Verona Pharma PlcADS | 80,000 | 130,000 | +50,000 | $3.72M | $8.25M | 2.69% | +$4.54M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 178,989 | 216,989 | +38,000 | $7.53M | $7.86M | 2.56% | +$327.1K |
| Scholar Rock Holding Corporation(SRRK) | 357,185 | 244,179 | -113,006 | $15.44M | $7.85M | 2.56% | -$7.59M |
| Vaxcyte, Inc.(PCVX) | 0 | 200,000 | +200,000 | $0 | $7.55M | 2.46% | +$7.55M |
| Vir Biotechnology, Inc.(VIR) | 897,862 | 1,068,062 | +170,200 | $6.59M | $6.92M | 2.25% | +$330.7K |
| Viridian Therapeutics, Inc.(VRDN) | 469,949 | 494,949 | +25,000 | $9.01M | $6.67M | 2.17% | -$2.34M |
| Insmed Incorporated(INSM) | 119,800 | 84,800 | -35,000 | $8.27M | $6.47M | 2.11% | -$1.80M |
| Edgewise Therapeutics, Inc.(EWTX) | 0 | 280,000 | +280,000 | $0 | $6.16M | 2.01% | +$6.16M |
| Catalyst Pharmaceuticals Inc | 349,649 | 249,649 | -100,000 | $7.30M | $6.05M | 1.97% | -$1.24M |
| Cytokinetics, Incorporated(CYTK) | 149,982 | 149,982 | 0 | $7.06M | $6.03M | 1.96% | -$1.03M |
| Enliven Therapeutics Inc | 394,538 | 289,538 | -105,000 | $8.88M | $5.70M | 1.86% | -$3.18M |
| Praxis Precision Medicines, Inc.(PRAX) | 0 | 145,502 | +145,502 | $0 | $5.51M | 1.80% | +$5.51M |
| Cidara Therapeutics Inc | 53,940 | 248,940 | +195,000 | $1.45M | $5.36M | 1.75% | +$3.91M |
| Alpha Cognition Inc. Common Stock(ACOG) | 755,867 | 967,867 | +212,000 | $4.45M | $5.11M | 1.66% | +$658.3K |
| Tectonic Therapeutic, Inc.(TECX) | 142,328 | 269,090 | +126,762 | $6.57M | $4.77M | 1.55% | -$1.81M |
| Forte Biosciences Inc | 609,225 | 609,225 | 0 | $13.84M | $4.73M | 1.54% | -$9.11M |
| Structure Therapeutics IncADS | 284,085 | 264,085 | -20,000 | $7.70M | $4.57M | 1.49% | -$3.13M |
| Metsera Inc | 0 | 150,000 | +150,000 | $0 | $4.08M | 1.33% | +$4.08M |
| Neuronetics, Inc.(STIM) | 0 | 1,100,000 | +1,100,000 | $0 | $4.05M | 1.32% | +$4.05M |
| Dyne Therapeutics, Inc.(DYN) | 0 | 358,837 | +358,837 | $0 | $3.75M | 1.22% | +$3.75M |
| Trevi Therapeutics, Inc.(TRVI) | 325,000 | 575,000 | +250,000 | $1.34M | $3.62M | 1.18% | +$2.28M |
| Maze Therapeutics, Inc.(MAZE) | 0 | 322,740 | +322,740 | $0 | $3.55M | 1.16% | +$3.55M |
| Janux Therapeutics, Inc.(JANX) | 74,691 | 129,691 | +55,000 | $4.00M | $3.50M | 1.14% | -$497.3K |
| Eledon Pharmaceuticals, Inc.(ELDN) | 1,126,637 | 1,025,221 | -101,416 | $4.64M | $3.48M | 1.13% | -$1.17M |
| BridgeBio Pharma, Inc.(BBIO) | 215,713 | 90,837 | -124,876 | $5.92M | $3.14M | 1.02% | -$2.78M |
| Cumberland Pharmaceuticals Inc.(CPIX) | 0 | 740,000 | +740,000 | $0 | $3.13M | 1.02% | +$3.13M |
| Keros Therapeutics, Inc.(KROS) | 0 | 274,009 | +274,009 | $0 | $2.79M | 0.91% | +$2.79M |
| Abeona Therapeutics Inc.(ABEO) | 533,581 | 533,581 | 0 | $2.97M | $2.54M | 0.83% | -$432.2K |
| Helus Pharma Inc(HELP) | 397,175 | 397,175 | 0 | $3.50M | $2.52M | 0.82% | -$985.0K |
| iBio, Inc.CON NEW(IBIO) | 599,913 | 599,913 | 0 | $1.47M | $2.41M | 0.79% | +$941.9K |
| Bright Minds Biosciences Inc.(DRUG) | 152,211 | 65,431 | -86,780 | $5.48M | $2.36M | 0.77% | -$3.12M |
| Evolus, Inc.(EOLS) | 373,265 | 193,265 | -180,000 | $4.12M | $2.32M | 0.76% | -$1.80M |
| Relay Therapeutics, Inc.(RLAY) | 693,308 | 743,308 | +50,000 | $2.86M | $1.95M | 0.63% | -$909.0K |
| Lexeo Therapeutics, Inc.(LXEO) | 499,301 | 550,029 | +50,728 | $3.29M | $1.91M | 0.62% | -$1.38M |
| Arcturus Therapeutics Holdings Inc.(ARCT) | 200,000 | 175,000 | -25,000 | $3.39M | $1.85M | 0.60% | -$1.54M |
| Kodiak Sciences Inc.(KOD) | 576,166 | 649,534 | +73,368 | $5.73M | $1.82M | 0.59% | -$3.91M |
| Oruka Therapeutics, Inc.(ORKA) | 0 | 175,000 | +175,000 | $0 | $1.80M | 0.58% | +$1.80M |
| Apellis Pharmaceuticals Inc COM | 3,594 | 75,000 | +71,406 | $114.7K | $1.64M | 0.53% | +$1.53M |
| Verve Therapeutics Inc | 169,991 | 358,393 | +188,402 | $958.7K | $1.64M | 0.53% | +$679.1K |
| Arvinas, Inc.(ARVN) | 0 | 229,900 | +229,900 | $0 | $1.61M | 0.53% | +$1.61M |
| Avalo Therapeutics, Inc.(AVTX) | 970,259 | 200,000 | -770,259 | $7.21M | $1.60M | 0.52% | -$5.61M |
| Vistagen Therapeutics, Inc.(VTGN) | 77,616 | 601,703 | +524,087 | $229.0K | $1.50M | 0.49% | +$1.28M |
| Rocket Pharmaceuticals, Inc.(RCKT) | 221,911 | 221,911 | 0 | $2.79M | $1.48M | 0.48% | -$1.31M |
| Ventyx Biosciences Inc | 1,092,590 | 1,217,590 | +125,000 | $2.39M | $1.40M | 0.46% | -$992.5K |
| Arcus Biosciences, Inc.(RCUS) | 378,363 | 163,363 | -215,000 | $5.63M | $1.28M | 0.42% | -$4.35M |
| Delcath Systems, Inc.(DCTH) | 100,365 | 100,365 | 0 | $1.21M | $1.28M | 0.42% | +$69.3K |
| Sangamo Therapeutics, Inc.(SGMOQ) | 1,860,179 | 1,860,179 | 0 | $1.90M | $1.22M | 0.40% | -$677.5K |
| Viking Therapeutics, Inc.(VKTX) | 0 | 50,000 | +50,000 | $0 | $1.21M | 0.39% | +$1.21M |
| Teladoc Health, Inc.(TDOC) | 0 | 150,000 | +150,000 | $0 | $1.19M | 0.39% | +$1.19M |
| Alector Inc | 950,000 | 950,000 | 0 | $1.80M | $1.17M | 0.38% | -$627.0K |
| OnKure Therapeutics, Inc.CL A(OKUR) | 253,754 | 253,754 | 0 | $2.18M | $1.09M | 0.36% | -$1.09M |
| Nuvation Bio Inc.CL A(NUVB) | 83,407 | 619,258 | +535,851 | $221.9K | $1.09M | 0.36% | +$868.0K |
| Nektar Therapeutics(NKTR) | 2,029,028 | 1,579,528 | -449,500 | $1.89M | $1.07M | 0.35% | -$812.9K |
| Tourmaline Bio Inc | 67,927 | 67,927 | 0 | $1.38M | $1.03M | 0.34% | -$344.4K |
| Immunic, Inc.(IMUX) | 1,614,170 | 914,170 | -700,000 | $1.61M | $996.4K | 0.32% | -$617.7K |
| Terns Pharmaceuticals Inc | 308,491 | 308,491 | 0 | $1.71M | $851.4K | 0.28% | -$857.6K |
| Solid Biosciences Inc | 0 | 230,000 | +230,000 | $0 | $851.0K | 0.28% | +$851.0K |
| 89bio Inc | 0 | 100,000 | +100,000 | $0 | $727.0K | 0.24% | +$727.0K |
| Olema Oncology, Inc.(OLMA) | 91,994 | 191,994 | +100,000 | $536.3K | $721.9K | 0.24% | +$185.6K |
| Veru Inc.(VERU) | 945,239 | 1,425,239 | +480,000 | $614.9K | $698.5K | 0.23% | +$83.6K |
| Lexicon Pharmaceuticals, Inc.(LXRX) | 1,550,000 | 1,417,952 | -132,048 | $1.14M | $653.4K | 0.21% | -$491.3K |
| Monte Rosa Therapeutics, Inc.(GLUE) | 311,575 | 136,575 | -175,000 | $2.16M | $633.7K | 0.21% | -$1.53M |
| Channel Therapeutics Corpora | 0 | 440,849 | +440,849 | $0 | $626.0K | 0.20% | +$626.0K |
| Pyxis Oncology, Inc.(PYXS) | 613,253 | 613,253 | 0 | $956.7K | $600.9K | 0.20% | -$355.7K |
| Inhibrx Biosciences, Inc.(INBX) | 42,122 | 42,122 | 0 | $648.7K | $589.3K | 0.19% | -$59.4K |
| Fulcrum Therapeutics, Inc.(FULC) | 200,096 | 200,096 | 0 | $940.5K | $576.3K | 0.19% | -$364.2K |
| Springworks Therapeutics Inc | 37,519 | 12,519 | -25,000 | $1.36M | $552.5K | 0.18% | -$803.1K |
| Kezar Life Sciences Inc COM NEW | 106,901 | 106,901 | 0 | $718.4K | $521.7K | 0.17% | -$196.7K |
| Tessera Defense and Homeland Security Inc.(HLSQ) | 892,976 | 892,976 | 0 | $652.0K | $496.2K | 0.16% | -$155.7K |
| Lyell Immunopharma, Inc.(LYEL) | 1,276,037 | 876,037 | -400,000 | $816.7K | $471.3K | 0.15% | -$345.4K |
| Iteos Therapeutics Inc | 78,585 | 78,585 | 0 | $603.5K | $469.2K | 0.15% | -$134.4K |
| Vigil Neuroscience Inc | 500,000 | 250,000 | -250,000 | $850.0K | $445.0K | 0.14% | -$405.0K |
| Aethlon Med Inc | 750,000 | 1,229,285 | +479,285 | $645.0K | $440.1K | 0.14% | -$204.9K |
| Alto Neuroscience, Inc.(ANRO) | 350,000 | 175,000 | -175,000 | $1.48M | $378.0K | 0.12% | -$1.10M |
| Mind Medicine Mindmed Inc | 62,691 | 62,691 | 0 | $436.3K | $366.7K | 0.12% | -$69.6K |
| Third Harmonic Bio Inc | 100,000 | 100,000 | 0 | $1.03M | $347.0K | 0.11% | -$682.0K |
| Ginkgo Bioworks Holdings, Inc.CL A(DNA) | 0 | 58,300 | +58,300 | $0 | $332.3K | 0.11% | +$332.3K |
| Tyra Biosciences, Inc.(TYRA) | 60,000 | 35,000 | -25,000 | $834.0K | $325.5K | 0.11% | -$508.5K |
| Acumen Pharmaceuticals, Inc.(ABOS) | 265,769 | 265,769 | 0 | $457.1K | $292.3K | 0.10% | -$164.8K |
| Cartesian Therapeutics, Inc.(RNAC) | 52,166 | 22,166 | -30,000 | $934.3K | $292.1K | 0.10% | -$642.1K |
| Spruce Biosciences Inc | 1,000,000 | 1,000,000 | 0 | $420.0K | $290.1K | 0.09% | -$129.9K |
| Allakos Inc | 971,950 | 1,171,950 | +200,000 | $1.18M | $266.7K | 0.09% | -$909.3K |
| Geron Corporation(GERN) | 0 | 150,000 | +150,000 | $0 | $238.5K | 0.08% | +$238.5K |
| Chemomab Therapeutics LtdADS | 213,052 | 213,052 | 0 | $385.6K | $232.2K | 0.08% | -$153.4K |
| Aclaris Therapeutics, Inc.(ACRS) | 350,000 | 150,900 | -199,100 | $868.0K | $230.9K | 0.08% | -$637.1K |
| Monopar Therapeutics Inc.(MNPR) | 5,908 | 5,908 | 0 | $130.0K | $215.1K | 0.07% | +$85.1K |
| Climb Bio, Inc.(CLYM) | 175,088 | 175,088 | 0 | $315.2K | $213.6K | 0.07% | -$101.6K |
| PepGen Inc.(PEPG) | 0 | 150,000 | +150,000 | $0 | $210.8K | 0.07% | +$210.8K |
| Anebulo Pharmaceuticals Inc | 157,720 | 157,720 | 0 | $265.0K | $205.0K | 0.07% | -$59.9K |
| Voyager Therapeutics, Inc.(VYGR) | 55,766 | 55,766 | 0 | $316.2K | $188.5K | 0.06% | -$127.7K |
| Elevation Oncology Inc | 690,050 | 690,050 | 0 | $388.2K | $178.8K | 0.06% | -$209.4K |
| Faeth Therapeutics, Inc.(FTH) | 649,963 | 449,963 | -200,000 | $318.5K | $177.3K | 0.06% | -$141.3K |